IBD

Inspire Corporate Bond Impact ETF
*Unless otherwise stated, data provided by FactSet.

IBD Fund Description

IBD tracks an equally weighted index of bonds issued by S&P 500-component companies that meet biblically responsible investing standards.

IBD Factset Analytics Insight

IBD charges a high fee for a principles-based bond strategy that aligns with evangelical Christian values. Starting from a broad universe of USD-denominated, investment-grade corporate bonds issued by companies in the S&P 500 Index, IBD screens out companies with any participation in activities that are inconsistent with biblical values as defined by the index sponsor. The fund then applies a proprietary model to evaluate companies based on primary business activities, products and services, philanthropy, legal activities, policies and practices to generate Inspire Impact Scores. The fund holds 250 bonds from the 200 highest-scoring issuers, applying maturity constraints to generate an intermediate-term portfolio. Overall, IBD is a potential fit for investors who share the faith-based principles defined by IBD’s sponsor and want to invest accordingly. However, vanilla investment-grade intermediate bond ETFs are available for a fraction of the cost.

IBD MSCI ESG Analytics Insight

Inspire Corporate Bond Impact ETF has an MSCI ESG Fund Rating of BBB based on a score of 5.54 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Inspire Corporate Bond Impact ETF ranks in the 52nd percentile within its peer group and in the 60th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

IBD Charts And Performance

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
Compare
Reset
Select ETFs to compare their performance:
PERFORMANCE [as of 12/12/19] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
IBD 0.55% 1.55% 7.73% 8.20% -- -- --
IBD (NAV) 0.33% 0.97% 7.70% 8.47% -- -- --
Bloomberg Barclays Intermediate Corporate Bond Index 0.41% 1.17% 9.51% 10.35% 4.43% 3.57% 4.45%
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

IBD Summary Data

Inspire
07/10/17
Open-Ended Fund
0.61%
$138.94M
$664.26K
0.48%

IBD Portfolio Data

4.03
--
2.74%
N/A
145

IBD Index Data

Equal
Principles-based
Bloomberg Barclays Intermediate Corporate Bond Index

IBD Portfolio Management

0.61%
--
--
--

IBD Tax Exposures

20.00% / 39.60%
--
Ordinary income
No

IBD Fund Structure

Open-Ended Fund
No
No
No Policy
N/A
N/A
Low
Daily
Cboe Book Viewer
Top Of Book
Last 10 Trades
Bats BZX Real-time Quote -

IBD Factset Analytics Block Liquidity

As of 12/13/19
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of IBD. IBD is rated a N/A out of 5.

IBD Tradability

25,779
$664.26K
11,877
$306.56K
0.48%
$0.12
0.29%
1.17% / -0.35%
None
100.00%
100,000
0.12
0.03%
--
0
$25.65
N/A

IBD Sector/Industry Breakdown


IBD
Segment Benchmark
68.30%
--
23.12%
--
8.58%
--

IBD Top 10 Holdings[View All]

2.68%
1.01%
0.99%
0.98%
0.97%
0.97%
0.97%
0.97%
0.97%
0.96%
11.47%

IBD Top 5 Countries


IBD
Segment Benchmark
97.57%
--
1.26%
--
0.96%
--
0.19%
--
0.02%
--

IBD Top 5 Currencies


IBD
Segment Benchmark
100.00%
--

IBD Performance Statistics

0.95
0.98
--
--
--

IBD MSCI ESG Ratings

5.54 / 10
60.12
51.97
3.04%
5.70%
453.60

IBD Holdings Statistics

4.16 years
4.03
2.74%
4.03
Medium
145
1.26%

IBD Avg Life Maturity Distribution

6.49%
14.37%
12.04%
22.20%
25.11%
19.79%
--
--
--

IBD OAS Breakdown

71.12%
28.49%
0.38%
--
--
--
--
--
--
--
--